Parenteral Nutrition Market to 2018 - Rising Incidence ofChronic Diseases such as Cancer, AIDS and Gastrointestinal(GI) Di...
5.4% of the total PN market, accounting for $157m sales value in 2011.By 2018, the PN market is forecast to be worth $4,86...
2 Parenteral Nutrition Market to 2018 - Introduction 93 Parenteral Nutrition Market to 2018 - Overview 103.1 Clinical Nutr...
6.5.1 Global Sales Value 316.5.2 Sales Value by Geography 317 Parenteral Nutrition Market - Marketed Products 327.1 Baxter...
9.2.3 Fresenius Acquires Novartis Nutrition and Nestle Espana in December 2007 639.2.4 Fresenius Kabi Acquires Infusia A.S...
Table 9: Parenteral Nutrition Market, Top Five Countries of Europe, Revenues ($m), 2004-2011 23Table 10: Parenteral Nutrit...
Figure 17: Parenteral Nutrition Market, Global, Product Profile - OLIMEL, 2012 32Figure 18: Parenteral Nutrition Market, G...
Upcoming SlideShare
Loading in …5
×

Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth

120 views
107 views

Published on

0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
120
On SlideShare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
1
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDS and Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth

  1. 1. Parenteral Nutrition Market to 2018 - Rising Incidence ofChronic Diseases such as Cancer, AIDS and Gastrointestinal(GI) Disorders, and Increased Use of Specialty Drugs DriveGrowthReport Details:Published:November 2012No. of Pages: 70Price: Single User License – US$3500Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDSand Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive GrowthSummaryGBI Research, the leading business intelligence provider, has released its latest research,“Parenteral Nutrition Market to 2018 - Rising Incidence of Chronic Diseases such as Cancer, AIDSand Gastrointestinal (GI) Disorders, and Increased Use of Specialty Drugs Drive Growth”. Itprovides in-depth analysis of the market size and drivers and barriers that affect the PN market.The report analyzes the markets for parenteral nutrition in the US, the top five countries in Europe(the UK, Germany, France, Italy and Spain) and Japan. Sales value is forecast until 2018 for keygeographies. Further, the report provides competitive benchmarking for the leading companiesand analyzes the mergers and acquisitions (M&A) and licensing agreements that shape the globalmarkets.The report is built using data and information sourced from proprietary databases, primary andsecondary research and in-house analysis by GBI Research’s team of industry experts.The PN market is rapidly growing with the increasing incidence of diseases such as cancer, AIDSand GI disorders including short bowel syndrome, ischemic bowel disease, pseudo obstructionand Crohn’s disease. The other major factor driving growth of the PN market is an increase in theelderly population in the developed countries. In 2011, the global PN market was estimated to beworth $2.9 billion, representing a CAGR of 6.3% between 2004 and 2011. The US market, withsales worth $1,476m in 2011, accounted for 50.7% of the total PN market. The market in the topfive countries in Europe was estimated to be $1,275m, the second largest PN market, and to havegrown at a CAGR of 5.4% between 2004 and 2011. The PN market in Japan registered a share of
  2. 2. 5.4% of the total PN market, accounting for $157m sales value in 2011.By 2018, the PN market is forecast to be worth $4,861m, representing a CAGR of 7.6% between2011 and 2018. The US is expected to remain the largest segment in the PN market with $2,492mof sales in 2018. The PN market in the top five countries in Europe will be the second largestsegment with $2,104m in revenues in 2018. Japan, which was the smallest segment in 2011, isexpected to register sales value of $265m in 2018, indicating a CAGR of 7.8% between 2011 and2018. The PN market M&A landscape demonstrated a fairly moderate level of activity between2004 and 2010, with seven major acquisition deals signed during the time period.Scope- Annualized market data for the PN market from 2004 to 2011, forecast forward to 2018.- Analysis of the PN market in the leading geographies of the world, which include the US, the topfive countries in Europe (the UK, Germany, France, Italy, Spain) and Japan.- Market segmentation of the PN market which includes the amino acid, lipids, carbohydrates andadditives market in the leading geographies.- Key drivers and barriers that have a significant impact on the market.- Competitive benchmarking of the leading companies. The key companies studied in this reportare Baxter, B. Braun, Fresenius Kabi, Hospira, Otsuka Pharmaceutical Factory, TerumoCorporation and Ajinomoto.- Key M&A activities, licensing agreements that have taken place between 2004 and 2011 in theglobal PN market.Reasons to buy- Develop market-entry and market expansion strategies by identifying the leading geographicmarkets poised for strong growth.- Reinforce R&D pipelines by identifying new target mechanisms which can produce first-in-classproducts with more efficiency and better safety.- Develop key strategic initiatives by understanding the key focus areas of leading companies.- Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfoliogaps.Get your copy of this report @http://www.reportsnreports.com/reports/206061-parenteral-nutrition-market-to-2018-rising-incidence-of-chronic-diseases-such-as-cancer-aids-and-gastrointestinal-gi-disorders-and-increased-use-of-specialty-drugs-drive-growth.htmlMajor points covered in Table of Contents of this report include1 Table of Contents1 Table of Contents 51.1 List of Tables 71.2 List of Figures 8
  3. 3. 2 Parenteral Nutrition Market to 2018 - Introduction 93 Parenteral Nutrition Market to 2018 - Overview 103.1 Clinical Nutrition 103.1.1 Enteral Nutrition 113.1.2 Parenteral Nutrition 114 Parenteral Nutrition Market to 2018 - Market Characterization and Forecasts 154.1 Revenue Forecasts 154.2 Parenteral Nutrition Market Drivers 164.2.1 Increase in the Incidence of Diseases such as Cancer, AIDS and GI Disorders that RequireNutrition Support 174.2.2 Increase in the Elderly Population will Drive PN Market Growth 174.2.3 The Home Parenteral Nutrition Sector will Witness Strong Market Growth 174.3 Parenteral Nutrition Market Restraints 174.3.1 Reimbursement Regulations will Hinder Market Growth in the US 174.3.2 Increasing Preference for Enteral Nutrition will Restrain Market Growth 174.3.3 Increasing Preference for Multi-chamber Bags Decreases Cost of Therapy 185 Parenteral Nutrition Market to 2018 - Geographical Landscape 195.1 Revenues by Geographical Segmentation 195.2 The US 215.2.1 Sales Value 215.2.2 Nutrient Market Segmentation 225.2.3 Key Products 225.3 Top Five Countries in Europe 235.3.1 Sales Value 235.3.2 Nutrient Market Segmentation 245.3.3 Key Products 245.4 Japan 255.4.1 Sales Value 255.4.2 Nutrient Market Segmentation 265.4.3 Key Products 266 Parenteral Nutrition Market to 2018 - Nutrient Market Segmentation 276.1 Overview 276.2 Amino Acids Market 286.2.1 Global Sales Value 286.2.2 Sales Value by Geography 286.3 Lipids Market 296.3.1 Global Sales Value 296.3.2 Sales Value by Geography 296.4 Carbohydrates Market 306.4.1 Global Sales Value 306.4.2 Sales Value by Geography 306.5 Additives Market 31
  4. 4. 6.5.1 Global Sales Value 316.5.2 Sales Value by Geography 317 Parenteral Nutrition Market - Marketed Products 327.1 Baxter International Inc. 327.1.1 OLIMEL 327.1.2 Clinimix 337.1.3 ClinOleic 20% 347.1.4 Clinisol 15% 357.2 B. Braun Melsungen AG 367.2.1 NuTRIflex System 367.2.2 Lipofundin 377.2.3 Aminoplasmal 387.2.4 FreAmine III 397.3 Fresenius Kabi AG 407.3.1 Intralipid 407.3.2 SmofKabiven 417.3.3 Dipeptiven 427.3.4 Omegaven 437.4 Hospira, Inc. 447.4.1 Aminosyn 447.4.2 Liposyn 467.5 Otsuka Pharmaceutical Factory Inc. 477.5.1 Elneopa 477.5.2 Neoparen 477.5.3 B-Fluid 487.6 Terumo Corporation 497.6.1 Unicaliq 497.6.2 Fulcaliq 508 Parenteral Nutrition Market to 2018 - Competitive Landscape 518.1 Market Share Analysis: Parenteral Nutrition 518.2 Competitive Profiling 528.2.1 Baxter International Inc. 528.2.2 B. Braun Melsungen AG 548.2.3 Fresenius Kabi AG 568.2.4 Hospira, Inc. 588.2.5 Otsuka Pharmaceutical Factory Inc. 608.2.6 Terumo Corporation 619 Parenteral Nutrition Market to 2018 - Strategic Consolidations 629.1 Overview 629.2 Major Acquisitions in the Parenteral Nutrition Market 639.2.1 Baxter International Completes Acquisition of Prism Pharma for $338m in April 2011 639.2.2 Baxter Acquires Willow Healthcare Services in July 2009 63
  5. 5. 9.2.3 Fresenius Acquires Novartis Nutrition and Nestle Espana in December 2007 639.2.4 Fresenius Kabi Acquires Infusia A.S. in December 2004 639.2.5 Fresenius Kabi Acquires Clinico GmbH in October 2005 639.2.6 Fresenius Kabi Acquires Isotec Nutrition from Alliance Pharmaceuticals in May 2004 639.2.7 Hospira Acquires Clayton Manufacturing Facility from Fresenius Kabi in June 2004 639.3 Major Agreements in the Parenteral Nutrition Market 649.3.1 Baxter Signs Agreement with Hanmi Pharmaceuticals in December 2010 649.3.2 Hospira Signs a Five-year Agreement with Novation in October 2010 649.3.3 B. Braun Signs Agreement with Amerinet Inc in October 2009 649.3.4 B. Braun Signs Agreement with Premier Purchasing Partners in August 2008 649.3.5 Hospira Announces New Contract with Premier Purchasing Partners in August 2008 659.3.6 Hospira Announces New Contract with HealthTrust Purchasing Group in February 2008 659.3.7 Baxter and Novation Sign Two-year Contract Extension in October 2007 659.3.8 Baxter Announces Plans to Form Parenteral Nutrition Joint Venture with Baiyunshan inChina in August 2007 659.3.9 B. Braun Signs Agreement with Curlin Medical in March 2006 659.3.10 Fresenius Kabi and Pharmatel Pty Ltd. Formed a Joint Venture in September 2004 6610 Parenteral Nutrition Market to 2018 - Appendix 6710.1 Market Definitions 6710.2 Abbreviations 6710.3 Bibliography 6810.4 Research Methodology 6910.4.1 Coverage 6910.4.2 Secondary Research 6910.4.3 Primary Research 6910.4.4 Section Methodology 7010.4.5 Expert Panel Validation 7010.5 Contact Us 7010.6 Disclaimer 701.1 List of TablesTable 1: Parenteral Nutrition Market, Global, Nutritional Status Assessment, 2011 10Table 2: Parenteral Nutrition Market, The US, A.S.P.E.N. Guidelines for Parenteral Nutrition, 200413Table 3: Parenteral Nutrition Market, Global, Revenues ($m), 2004-2011 15Table 4: Parenteral Nutrition Market, Global, Revenue Forecasts ($m), 2011-2018 15Table 5: Parenteral Nutrition Market, Global, Revenue by Geographical Segmentation ($m), 2004-2011 19Table 6: Parenteral Nutrition Market, Global, Revenue Forecasts by Geographical Segmentation($m), 2011-2018 20Table 7: Parenteral Nutrition Market, The US, Revenues ($m), 2004-2011 21Table 8: Parenteral Nutrition Market, The US, Revenue Forecasts ($m), 2011-2018 21
  6. 6. Table 9: Parenteral Nutrition Market, Top Five Countries of Europe, Revenues ($m), 2004-2011 23Table 10: Parenteral Nutrition Market, Top Five Countries of Europe, Revenue Forecasts ($m),2011-2018 23Table 11: Parenteral Nutrition Market, Japan, Revenues ($m), 2004-2011 25Table 12: Parenteral Nutrition Market, Japan, Revenue Forecasts ($m), 2011-2018 25Table 13: Parenteral Nutrition Market, Amino Acids Revenue by Geographical Segmentation ($m),2011 28Table 14: Parenteral Nutrition Market, Lipids Revenue by Geographical Segmentation ($m), 201129Table 15: Parenteral Nutrition Market, Carbohydrates Revenue by Geographical Segmentation($m), 2011 30Table 16: Parenteral Nutrition Market, Additives Revenue by Geographical Segmentation ($m),2011 31Table 17: Parenteral Nutrition Market, Global, Product Composition - Lipofundin, 2012 37Table 18: Parenteral Nutrition Market, Global, Product Composition - Aminoplasmal, 2012 38Table 19: Parenteral Nutrition Market, Global, Product Composition - Aminosyn, 2012 45Table 20: Parenteral Nutrition Market, Global, Strategic Consolidations Overview, 2012 621.2 List of FiguresFigure 1: Parenteral Nutrition Market, Global, Nutritional Support Algorithm 11Figure 2: Parenteral Nutrition Market, Global, Nutrition Requirements for TPN, 2012 12Figure 3: Parenteral Nutrition Market, Global, Revenues ($m), 2004-2018 15Figure 4: Parenteral Nutrition Market, Global, Drivers and Barriers, 2012 16Figure 5: Parenteral Nutrition Market, Global, Revenue by Geographical Segmentation ($m),2004-2018 19Figure 6: Parenteral Nutrition Market, The US, Historic Revenue and Forecasts ($m), 2004-201821Figure 7: Parenteral Nutrition Market, The US, Key Products, 2012 22Figure 8: Parenteral Nutrition Market, Top Five Countries of Europe, Historic Revenue andForecasts ($m), 2004-2018 23Figure 9: Parenteral Nutrition Market, Top Five Countries in Europe, Key Products, 2011 24Figure 10: Parenteral Nutrition Market, Japan, Revenue Forecasts ($m), 2004-2018 25Figure 11: Parenteral Nutrition Market, Japan, Key Products, 2011 26Figure 12: Parenteral Nutrition Market, Global, Nutrient Market Segmentation (%), 2011 27Figure 13: Parenteral Nutrition Market, Amino Acids Revenue by Geographical Segmentation($m), 2011 28Figure 14: Parenteral Nutrition Market, Lipids Revenue by Geographical Segmentation ($m), 201129Figure 15: Parenteral Nutrition Market, Carbohydrates Revenue by Geographical Segmentation($m), 2011 30Figure 16: Parenteral Nutrition Market, Additives Revenue by Geographical Segmentation ($m),2011 31
  7. 7. Figure 17: Parenteral Nutrition Market, Global, Product Profile - OLIMEL, 2012 32Figure 18: Parenteral Nutrition Market, Global, Product Profile - Clinimix, 2012 33Figure 19: Parenteral Nutrition Market, Global, Product Profile - ClinOleic 20%, 2012 34Figure 20: Parenteral Nutrition Market, Global, Product Profile - Clinisol 15%, 2012 35Figure 21: Parenteral Nutrition Market, Global, Product Profile - NuTRIflex, 2012 36Figure 22: Parenteral Nutrition Market, Global, Product Profile - Lipofundin, 2012 37Figure 23: Parenteral Nutrition Market, Global, Product Profile - Aminoplasmal, 2012 38Figure 24: Parenteral Nutrition Market, Global, Product Profile - FreAmine III, 2012 39Figure 25: Parenteral Nutrition Market, Global, Product Profile-Intralipid, 2012 40Figure 26: Parenteral Nutrition Market, Global, Product Profile - SmofKabiven, 2012 41Figure 27: Parenteral Nutrition Market, Global, Product Profile - Dipeptiven, 2012 42Figure 28: Parenteral Nutrition Market, Global, Product Profile - Omegaven, 2012 43Figure 29: Parenteral Nutrition Market, Global, Product Profile - Aminosyn, 2012 44Figure 30: Parenteral Nutrition Market, Global, Product Profile - Liposyn, 2012 46Figure 31: Parenteral Nutrition Market, Global, Product Profile - Neoparen, 2012 47Figure 32: Parenteral Nutrition Market, Global, Product Profile - B-Fluid, 2012 48Figure 33: Parenteral Nutrition Market, Global, Product Profile - Unicaliq, 2012 49Figure 34: Parenteral Nutrition Market, Global, Product Profile - Fulcaliq, 2012 50Figure 35: Parenteral Nutrition Market, Global, Market Share of Top Manufacturers (%), 2011 51Figure 36: Parenteral Nutrition Market to 2018, Global, Company Profile - Baxter International Inc.,2012 52Figure 37: Parenteral Nutrition Market, Global, SWOT Analysis - Baxter International Inc., 2012 53Figure 38: Parenteral Nutrition Market to 2018, Global, Company Profile - B. Braun MelsungenAG, 2012 54Figure 39: Parenteral Nutrition Market, Global, SWOT Analysis - B. Braun Melsungen AG, 2012 55Figure 40: Parenteral Nutrition Market, Global, Company Profile - Fresenius Kabi AG, 2012 56Figure 41: Parenteral Nutrition Market, Global, SWOT Analysis - Fresenius Kabi AG, 2012 57Figure 42: Parenteral Nutrition Market, Global, Company Profile - Hospira Inc., 2012 58Figure 43: Parenteral Nutrition Market, Global, SWOT Analysis - Hospira Inc., 2012 59Figure 44: Parenteral Nutrition Market, Global, Company Profile - Otsuka Pharmaceutical FactoryInc., 2012 60Figure 45: Parenteral Nutrition Market, Global, Company Profile - Terumo Corporation, 2012 61Figure 46: Parenteral Nutrition Market, Global, Strategic Consolidations Overview (%), 2012 62Contact: sales@reportsandreports.com for more information.

×